{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:26:41Z","timestamp":1785403601321,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018818","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejps.2024.106920","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:22:59Z","timestamp":1727716979000},"page":"106920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A new cannabigerol derivative, LE-127\/2, induces autophagy mediated cell death in human cutaneous melanoma cells"],"prefix":"10.1016","volume":"203","author":[{"given":"\u00c1gnes","family":"T\u00f3saki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"Kir\u00e1ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter Bogl\u00e1rka","family":"L\u0151rincz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vir\u00e1g","family":"Vass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"T\u00e1nczos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Bereczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Herczegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Remenyik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"T\u00f3saki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzs\u00e9bet","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ejps.2024.106920_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/ma12233914","article-title":"Comment on \"Dual-Band Perfect Metamaterial Absorber Based on an Asymmetric H-Shaped Structure for Terahertz Waves [Materials] (2018) [2193; https:\/\/doi.org\/10.3390\/ma11112193]","volume":"12","author":"Ahmed","year":"2019","journal-title":"Materials. (Basel)"},{"issue":"2","key":"10.1016\/j.ejps.2024.106920_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020470","article-title":"Mechanisms of Melanoma Progression and Treatment Resistance: role of Cancer Stem-like Cells","volume":"16","author":"Al Hmada","year":"2024","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.ejps.2024.106920_bib0003","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1479-5876-10-85","article-title":"The role of BRAF V600 mutation in melanoma","volume":"10","author":"Ascierto","year":"2012","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.ejps.2024.106920_bib0004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00403-017-1720-9","article-title":"Laser and light-based therapy for cutaneous and soft-tissue metastases of malignant melanoma: a systematic review","volume":"309","author":"Austin","year":"2017","journal-title":"Arch. Dermatol. Res."},{"issue":"7","key":"10.1016\/j.ejps.2024.106920_bib0005","article-title":"Hyperforin Enhances Heme Oxygenase-1 Expression Triggering Lipid Peroxidation in BRAF-Mutated Melanoma Cells and Hampers the Expression of Pro-Metastatic Markers","volume":"12","author":"Cardile","year":"2023","journal-title":"Antioxidants. (Basel)"},{"issue":"11","key":"10.1016\/j.ejps.2024.106920_bib0006","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejps.2024.106920_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.903374","article-title":"The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract","volume":"12","author":"Ferris","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2024.106920_bib0008","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-med-050410-105655","article-title":"Targeting metastatic melanoma","volume":"63","author":"Flaherty","year":"2012","journal-title":"Annu. Rev. Med."},{"issue":"18","key":"10.1016\/j.ejps.2024.106920_bib0009","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ejps.2024.106920_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19040969","article-title":"Preclinical Evaluation of Vemurafenib as Therapy for BRAF(V600E) Mutated Sarcomas","volume":"19","author":"Gouravan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2024.106920_bib0011","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ccell.2018.11.008","article-title":"p62\/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors","volume":"35","author":"Karras","year":"2019","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.ejps.2024.106920_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137675","article-title":"Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines","volume":"10","author":"Koukourakis","year":"2015","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.ejps.2024.106920_bib0013","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/pcmr.12264","article-title":"Adaptive resistance to RAF inhibitors in melanoma","volume":"27","author":"Kugel","year":"2014","journal-title":"Pigment. Cell Melanoma Res."},{"issue":"23","key":"10.1016\/j.ejps.2024.106920_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235918","article-title":"The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling","volume":"14","author":"Lah","year":"2022","journal-title":"Cancers. (Basel)"},{"issue":"2","key":"10.1016\/j.ejps.2024.106920_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020340","article-title":"Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma","volume":"10","author":"Lah","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2024.106920_bib0016","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.phymed.2018.03.027","article-title":"Panduratin A induces protective autophagy in melanoma via the AMPK and mTOR pathway","volume":"42","author":"Lai","year":"2018","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.ejps.2024.106920_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061211","article-title":"Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers. (Basel)"},{"issue":"3","key":"10.1016\/j.ejps.2024.106920_bib0018","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ptr.6273","article-title":"HIF-1\u03b1\/VEGF signaling-mediated epithelial-mesenchymal transition and angiogenesis is critically involved in anti-metastasis effect of luteolin in melanoma cells","volume":"33","author":"Li","year":"2019","journal-title":"PhytOther Res."},{"issue":"3","key":"10.1016\/j.ejps.2024.106920_bib0019","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2024.106920_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5149417","article-title":"Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K\/Akt\/mTOR Signaling Pathway","volume":"2020","author":"Long","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.ejps.2024.106920_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071648","article-title":"Targeting p53 for Melanoma Treatment: counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance","volume":"13","author":"Loureiro","year":"2021","journal-title":"Cancers. (Basel)"},{"issue":"1","key":"10.1016\/j.ejps.2024.106920_bib0022","doi-asserted-by":"crossref","first-page":"19618","DOI":"10.1038\/s41598-023-45565-7","article-title":"Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivatives","volume":"13","author":"L\u0151rincz","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejps.2024.106920_bib0023","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.clindermatol.2012.08.016","article-title":"Chemotherapy in the management of advanced cutaneous malignant melanoma","volume":"31","author":"Luke","year":"2013","journal-title":"Clin. Dermatol."},{"issue":"3","key":"10.1016\/j.ejps.2024.106920_bib0024","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1080\/09546634.2020.1817838","article-title":"Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications","volume":"33","author":"Mandel","year":"2022","journal-title":"J. Dermatolog. Treat."},{"issue":"2","key":"10.1016\/j.ejps.2024.106920_bib0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41419-017-0059-7","article-title":"Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies","volume":"9","author":"Mattia","year":"2018","journal-title":"Cell Death. Dis."},{"issue":"12","key":"10.1016\/j.ejps.2024.106920_bib0026","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00432-018-2726-1","article-title":"Melanoma treatment: from conventional to nanotechnology","volume":"144","author":"Mishra","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ejps.2024.106920_bib0027","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11864-019-0643-4","article-title":"Malignant Melanoma: autoimmunity and Supracellular Messaging as New Therapeutic Approaches","volume":"20","author":"Motofei","year":"2019","journal-title":"Curr. Treat. Options. Oncol."},{"key":"10.1016\/j.ejps.2024.106920_bib0028","first-page":"21","article-title":"Clonogenic cell survival assay","volume":"110","author":"Munshi","year":"2005","journal-title":"Methods Mol. Med."},{"issue":"2","key":"10.1016\/j.ejps.2024.106920_bib0029","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1574887111666160330120712","article-title":"Immune Check Point Inhibitors Combination in Melanoma: worth the Toxicity?","volume":"11","author":"Orloff","year":"2016","journal-title":"Rev. Recent. Clin. Trials"},{"issue":"12","key":"10.1016\/j.ejps.2024.106920_bib0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/1389557516666160211120157","article-title":"Phytochemicals for the Management of Melanoma","volume":"16","author":"Pal","year":"2016","journal-title":"Mini. Rev. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejps.2024.106920_bib0031","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9610(78)90171-X","article-title":"Metastatic pattern of malignant melanoma. A study of 216 autopsy cases","volume":"135","author":"Patel","year":"1978","journal-title":"Am. J. Surg."},{"issue":"4","key":"10.1016\/j.ejps.2024.106920_bib0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/biom12040491","article-title":"Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: cytotoxic, Anti-Proliferative, and Anti-Migratory Activities","volume":"12","author":"Peeri","year":"2022","journal-title":"Biomolecules."},{"issue":"17","key":"10.1016\/j.ejps.2024.106920_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174384","article-title":"Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF\/MEK Targeted Therapy: multicenter Real-World Report","volume":"15","author":"Placzke","year":"2023","journal-title":"Cancers. (Basel)"},{"issue":"12","key":"10.1016\/j.ejps.2024.106920_bib0034","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/ijd.12724","article-title":"Bench to bedside: mechanistic principles of targeting the RAF kinase in melanoma","volume":"53","author":"Rajakulendran","year":"2014","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.ejps.2024.106920_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ptr.7263","article-title":"Efficacy and safety of therapeutic use of cannabis derivatives and their synthetic analogs: overview of systematic reviews","volume":"36","author":"Riera","year":"2022","journal-title":"PhytOther Res."},{"key":"10.1016\/j.ejps.2024.106920_bib0036","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2019.07.004","article-title":"Enzyme responsive drug delivery systems in cancer treatment","volume":"308","author":"Shahriari","year":"2019","journal-title":"J. Control Release"},{"issue":"5","key":"10.1016\/j.ejps.2024.106920_bib0037","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/era.13.24","article-title":"Vemurafenib in melanoma","volume":"13","author":"Shaw","year":"2013","journal-title":"Expert. Rev. AntiCancer Ther."},{"issue":"1","key":"10.1016\/j.ejps.2024.106920_bib0038","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41420-023-01581-0","article-title":"Different types of cell death and their shift in shaping disease","volume":"9","author":"Shen","year":"2023","journal-title":"Cell Death. Discov."},{"issue":"3","key":"10.1016\/j.ejps.2024.106920_bib0039","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11912-010-0095-2","article-title":"B-RAF inhibitors: an evolving role in the therapy of malignant melanoma","volume":"12","author":"Shepherd","year":"2010","journal-title":"Curr. Oncol. Rep."},{"issue":"6","key":"10.1016\/j.ejps.2024.106920_bib0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/cam4.140","article-title":"Ipilimumab and radiation therapy for melanoma brain metastases","volume":"2","author":"Silk","year":"2013","journal-title":"Cancer Med."},{"issue":"20","key":"10.1016\/j.ejps.2024.106920_bib0041","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","article-title":"Apoptosis and melanoma chemoresistance","volume":"22","author":"Soengas","year":"2003","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ejps.2024.106920_bib0042","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1183\/09031936.00089407","article-title":"Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells","volume":"34","author":"Stamatiou","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejps.2024.106920_bib0043","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fonc.2016.00236","article-title":"Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma","volume":"6","author":"Tang","year":"2016","journal-title":"Front. Oncol."},{"issue":"14","key":"10.1016\/j.ejps.2024.106920_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141919","article-title":"Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets","volume":"12","author":"T\u00f3v\u00e1ri","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ejps.2024.106920_bib0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051049","article-title":"Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells","volume":"13","author":"Tran","year":"2021","journal-title":"Cancers. (Basel)"},{"issue":"4","key":"10.1016\/j.ejps.2024.106920_bib0046","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00418-008-0406-y","article-title":"Autophagy-physiology and pathophysiology","volume":"129","author":"Uchiyama","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejps.2024.106920_bib0047","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.freeradbiomed.2021.01.012","article-title":"Antioxidant function of phytocannabinoids: molecular basis of their stability and cytoprotective properties under UV-irradiation","volume":"164","author":"Vacek","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejps.2024.106920_bib0048","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejso.2016.07.001","article-title":"Neo)adjuvant systemic therapy for melanoma","volume":"43","author":"van Zeijl","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ejps.2024.106920_bib0049","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/bjd.17333","article-title":"Harnessing autophagy to overcome mitogen-activated protein kinase kinase inhibitor-induced resistance in metastatic melanoma","volume":"180","author":"Verykiou","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.ejps.2024.106920_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060854","article-title":"Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways","volume":"12","author":"Viereckl","year":"2022","journal-title":"Biomolecules."},{"issue":"6","key":"10.1016\/j.ejps.2024.106920_bib0051","article-title":"Cytoprotective Role of Heme Oxygenase-1 in Cancer Chemoresistance: focus on Antioxidant, Antiapoptotic, and Pro-Autophagy Properties","volume":"12","author":"Wang","year":"2023","journal-title":"Antioxidants. (Basel)"},{"issue":"8","key":"10.1016\/j.ejps.2024.106920_bib0052","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/bph.14958","article-title":"Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: opposite roles of CB(1) \/CB(2) versus GPR55 receptors","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejps.2024.106920_bib0053","article-title":"Effect of Heme Oxygenase-1 on Melanoma Development in Mice-Role of Tumor-Infiltrating Immune Cells","volume":"9","author":"Was","year":"2020","journal-title":"Antioxidants. (Basel)"},{"key":"10.1016\/j.ejps.2024.106920_bib0054","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-319-22539-5_8","article-title":"Chemotherapy for Melanoma","volume":"167","author":"Wilson","year":"2016","journal-title":"Cancer Treat. Res."},{"issue":"1","key":"10.1016\/j.ejps.2024.106920_bib0055","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2219164","article-title":"Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression","volume":"12","author":"Wyrobnik","year":"2023","journal-title":"Oncoimmunology."},{"issue":"6","key":"10.1016\/j.ejps.2024.106920_bib0056","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1158\/0008-5472.CAN-05-2674","article-title":"Activation of stat3 in human melanoma promotes brain metastasis","volume":"66","author":"Xie","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ejps.2024.106920_bib0057","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3390\/curroncol30020124","article-title":"Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) Expression","volume":"30","author":"Yang","year":"2023","journal-title":"Curr. Oncol."},{"issue":"12","key":"10.1016\/j.ejps.2024.106920_bib0058","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41422-018-0090-y","article-title":"Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis","volume":"28","author":"Zhou","year":"2018","journal-title":"Cell Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T09:26:17Z","timestamp":1730366777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":58,"alternative-id":["S0928098724002331"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106920","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new cannabigerol derivative, LE-127\/2, induces autophagy mediated cell death in human cutaneous melanoma cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106920"}}